Navigation Links
Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
Date:5/26/2009

EXTON, Pa., May 26 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) announced that its cartilage repair device has been highlighted in two podium presentations at the 8th World Congress of the International Cartilage Repair Society (ICRS) Meeting held in Miami, FL on May 23-26, 2009. The pre-clinical findings demonstrate the potential for Kensey Nash's proprietary tissue engineering implant to repair damaged articular cartilage.

These presentations detailed two studies, which have been designed to evaluate the safety and performance of the Kensey Nash Cartilage Repair Device (CRD) in a simulated clinical application prior to initiating a formal clinical investigation, which is ultimately necessary for U.S. FDA marketing approval. The first study, being performed with the Cornell University College of Veterinary Medicine, demonstrated superior healing characteristics for the CRD in a preclinical study when compared with microfracture after 4 months of treatment. The microfracture technique is the current standard for articular cartilage treatment. The second study, performed in collaboration with the Comparative Orthopaedic Research Laboratory at the New Bolton Center of the University of Pennsylvania School of Veterinary Medicine, examined the CRD in a pre-clinical model at 6 and 12 months. This study indicated that cartilage defects treated with the CRD repaired more rapidly than controls. The data also suggested that the de novo tissue formed in the CRD at 12 months is mechanically sound and durable, and resembles natural articular cartilage. Both studies showed that the CRD had the ability to remain at the site of implantation independently, providing a significant advantage over devices requiring additional means of fixation.

"The results on our cartilage repair device are en
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kensey Nash Announces IDE Submission for Cartilage Repair Device
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... and NINGBO, China , ... the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced ... development of generic pharmaceuticals, primarily targeting the ... the agreement, Amerigen and Menovo will jointly develop products ... States . Menovo will be responsible for manufacturing ...
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... WARSAW, Ind. , Aug. 27, 2014  Zimmer ... in musculoskeletal care, announced that it will be participating ... the Grand Hyatt in New York, New ... David Dvorak , President and CEO of Zimmer, will ... Binder , President and CEO of Biomet, will join ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Ambit Announces Participation At Baird 2014 Health Care Conference 2
(Date:8/27/2014)... FL (PRWEB) August 27, 2014 The ... September 5th, 6th and 7th at the Florida State ... Festival celebrates all Latino art and cultures from around ... present their platinum sponsor Go Smart Mobile and Univision ... Action Festival is expecting an estimate of 4,000 people ...
(Date:8/27/2014)... Dennis Thompson HealthDay Reporter ... who has been mugged in a dark alley will likely ... a fear of being attacked. But neuroscientists working with ... memories are linked with positive and negative emotions. And in ... attached to a memory. In essence, they made once-reluctant ...
(Date:8/27/2014)... 28, 2014 BRIC Laparoscopes Market Outlook ... provides key market data on the BRIC Laparoscopes market. ... volume (in units) and average prices (in US dollars) ... and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and ... of advantages to the patient with laparoscopic surgery versus ...
(Date:8/27/2014)... Dr. Stewart Shofner and Dr. Kevin ... suffering from impaired vision. Some of the most common ... . Recently, Dr. Shofner has noticed a significant increase ... and also online. To help patients understand the facts, ... , 1)    Myth: People with perfect vision won’t develop glaucoma. ...
(Date:8/27/2014)... August 27, 2014 The extensive ... nurses by healthcare research group Black Book Rankings ... not adequately staffed, supplied or built to care ... Book initiated this annual survey to gain stakeholder ... infection control, epidemiology and emergency preparedness systems,” said ...
Breaking Medicine News(10 mins):Health News:Marc Anthony to Perform at "Nieves Productions" Latinos in Action Festival 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4
... ... in technology will have a bottom-line impact on people’s health. While ... is a new breed of technology aimed at preventative, integrative health solutions. ... tracking tools, providing members ways to track, understand, and improve their health ...
... , Jan. 19 The National Theatre for Children ... with the only global entertainment brand dedicated to kids health, ... healthy exercise to the kids and families who need it most. ... will tour a curriculum-based and interactive live show – performed by ...
... Birth Defect Research Reveals Craniofacial & Brain ... CELEBRATION, Fla. , Jan. 19 Nearly two-thirds of ... Birth Defect Registry (NBDR) also suffer from structural birth defects, ... . The group reported that most of the defects affect the ...
... acids in the solution reduce inflammation, researchers note , ... to intravenous solutions proved beneficial for intensive care patients ... a new study finds. , The study, published Jan. ... 13 patients who received fish oil in the normal ...
... ... Screening and Treatment , ... Heights, NJ (Vocus) January 19, 2010 -- During Glaucoma Awareness Month, Summit Medical Group wants ... the eyes that causes vision loss. Because there often are no symptoms in its early ...
... ... satisfied with their health insurers, according to a study released today by ... employers of all sizes are taking a critical look at their health ... looking to their health plan providers for information, technology and strategies to ...
Cached Medicine News:Health News:Online Tools to Transform the Way People Manage Their Health 2Health News:Online Tools to Transform the Way People Manage Their Health 3Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 2Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 3Health News:World's #1 Health Brand for Kids Joins Forces With World's #1 In-School Children's Theatre 4Health News:High Rates of Birth Defects Found in Autistic Children 2Health News:Adding Fish Oil to IV May Speed Sepsis Recovery 2Health News:January is Glaucoma Awareness Month 2Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 2Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 3Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 4Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 5Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 6Health News:Employer Satisfaction with Health Insurers is Declining, Finds PricewaterhouseCoopers Study 7
... head design has been carefully considered with both ... head ensures the optimum viewing angle and the ... laser aligned for perfect focus where it is ... paper. This along with Keeler's wide angle ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
... 200S is the first hand-held ... of patented aspherical optics (U.S. ... of corrective lenses from 36 ... diopter steps. A perfectly-focused image ...
... The ophthalmoscope with superior aspherical optics. ... illumination and observation beam by means of ... iris reflex (Gullstrand-principle). The Beta 200 allows ... illuminated section of the retina even with ...
Medicine Products: